Comparative analysis of the antiviral effects mediated by type I and III interferons in hepatitis B virus infected hepatocytes.
J. Infect. Dis. 220, 567-577 (2019)
Background. Type III interferons (IFNs) (lambda 1-3) activate similar signaling cascades as type I IFNs (alpha and beta) via different receptors. Since IFN-alpha and lymphotoxin-beta activate cytosine deamination and subsequent purging of nuclear hepatitis B virus (HBV) DNA, we investigated whether IFN-beta and -lambda may also induce these antiviral effects in differentiated HBV-infected hepatocytes.Methods. After determining the biological activity of IFN-alpha 2,-beta 1, -lambda 1, and -lambda 2 in differentiated hepatocytes, their antiviral effects were analyzed in HBV-infected primary human hepatocytes and HepaRG cells.Results. Type I and III IFNs reduced nuclear open-circle DNA and covalently closed circular DNA (cccDNA) levels in HBV-infected cells. IFN-beta and -lambda were at least as efficient as IFN-alpha. Differential DNA-denaturing polymerase chain reaction and sequencing analysis revealed G-to-A sequence alterations of HBV cccDNA in IFN-alpha, -beta, and -lambda-treated liver cells indicating deamination. All IFNs induced apolipoprotein B messenger RNA-editing enzyme-catalytic polypeptide-like (APOBEC) deaminases 3A and 3G within 24 hours of treatment, but IFN-beta and -lambda induced longer-lasting expression of APOBEC deaminases in comparison to IFN-alpha.Conclusions. IFN-beta, IFN-lambda 1, and IFN-lambda 2 induce cccDNA deamination and degradation at least as efficiently as IFN-alpha, indicating that these antiviral cytokines are interesting candidates for the design of new therapeutic strategies aiming at cccDNA reduction and HBV cure.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Hbv ; Interferon-lambda ; Interferon-beta ; Heparg Cells ; Primary Human Hepatocytes; Gene-expression; Replication; Alpha; Dna; Induction; Lambda
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
0022-1899
e-ISSN
1537-6613
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 220,
Heft: 4,
Seiten: 567-577
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Oxford University Press
Verlagsort
Journals Dept, 2001 Evans Rd, Cary, Nc 27513 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Immune Response and Infection
PSP-Element(e)
G-502700-003
Förderungen
Copyright
Erfassungsdatum
2019-04-04